Denis Poddubnyy
Overview
Explore the profile of Denis Poddubnyy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
261
Citations
5034
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rios Rodriguez V, Sanchez-Riera L, Haibel H, Hoppner C, Torgutalp M, Proft F, et al.
Ther Adv Musculoskelet Dis
. 2025 Mar;
17:1759720X251324429.
PMID: 40078463
Background: Early treatment initiation is one of the strongest predictors of good treatment response in axial spondyloarthritis (axSpA). Recently, the Assessment in SpondyloArthritis International Society (ASAS) defined early axSpA as...
2.
Rios Rodriguez V, Essex M, Poddubnyy D
Curr Opin Rheumatol
. 2025 Feb;
PMID: 39968641
Purpose Of Review: This review provides an updated overview of the gut microbiota's involvement in spondyloarthritis (SpA) from a clinical perspective. It explores mechanisms by which the gut microbiota may...
3.
Mistegaard C, Troldborg A, Torgutalp M, Loft A, Thiel S, Muche B, et al.
Rheumatol Adv Pract
. 2025 Feb;
9(1):rkaf007.
PMID: 39959130
Objectives: To investigate lectin pathway proteins (LPPs) and complement activation marker C3dg as biomarkers for disease activity and treatment response in a multicentre, randomized controlled trial of axial spondyloarthritis (axSpA)...
4.
Poddubnyy D, Navarro-Compan V, Torgutalp M, Arends S, Aydin S, Battista S, et al.
Ann Rheum Dis
. 2025 Feb;
PMID: 39955166
Objectives: To develop a consensus-based expert definition of difficult-to-manage (D2M) axial spondyloarthritis (axSpA), incorporating treatment-refractory (TR) disease. Methods: A literature review was conducted in 2022 to identify potential definitions for...
5.
van der Heijde D, Navarro-Compan V, Landewe R, Sieper J, van Gaalen F, Gensler L, et al.
Ann Rheum Dis
. 2025 Feb;
84(3):382-387.
PMID: 39948004
Objective: To describe the role of the Assessment of SpondyloArthritis interntational Society (ASAS) over the past 30 years in the understanding of the field of spondyloarthritis. Methods: A narrative review...
6.
Aleixo C, Ziegeler K, Ulas S, Diekhoff T, Greese J, Lindholz M, et al.
RMD Open
. 2025 Feb;
11(1).
PMID: 39922705
Objectives: Anatomical variation of the sacroiliac (SI) joints is common and specific variants are associated with erosions and bone marrow oedema on imaging. Our investigation aims to evaluate whether anatomical...
7.
Van den Bosch F, Deodhar A, Poddubnyy D, Maksymowych W, van der Heijde D, Kim T, et al.
Arthritis Res Ther
. 2025 Feb;
27(1):23.
PMID: 39905436
Background: In SELECT-AXIS 2, upadacitinib improved the signs and symptoms of active non-radiographic axial spondyloarthritis (nr-axSpA) through 52 weeks versus placebo and was well tolerated. Here, we evaluated the efficacy...
8.
Deodhar A, Navarro-Compan V, Poddubnyy D, Gensler L, Ramiro S, Tomita T, et al.
RMD Open
. 2025 Jan;
11(1).
PMID: 39890205
Objective: Assess long-term safety, tolerability and efficacy of bimekizumab in ankylosing spondylitis (radiographic axial spondyloarthritis (r-axSpA)). Methods: Patients with active r-axSpA completing the dose-ranging 48-week randomised controlled trial could enrol...
9.
Torgutalp M, Rademacher J, Proft F, Hermann K, Althoff C, Haibel H, et al.
RMD Open
. 2025 Jan;
11(1.
PMID: 39762123
Objectives: In this post-hoc analysis of ESTHER trial, we aimed to investigate the longitudinal relationship between inflammation on MRI and the achievement of inactive disease/low disease activity in patients with...
10.
Rademacher J, Torgutalp M, Hempel C, Proft F, Haibel H, Protopopov M, et al.
RMD Open
. 2024 Dec;
10(4.
PMID: 39740933
Objectives: The objective of this study is to investigate lipopolysaccharid-binding protein (LBP), zonulin and calprotectin as markers of bacterial translocation, disturbed gut barrier and intestinal inflammation in patients with radiographic...